sepsis - Nursing Case Study

Pathophysiology

• Primary mechanism: Dysregulated host response to infection triggers widespread inflammation, leading to the release of pro-inflammatory cytokines, causing systemic inflammation and tissue damage.

• Secondary mechanism: Endothelial dysfunction occurs as inflammatory mediators increase vascular permeability, resulting in hypotension and impaired tissue perfusion.

• Key complication: The combination of systemic inflammation and endothelial dysfunction can lead to multi-organ dysfunction syndrome (MODS), where multiple organ systems fail due to inadequate blood supply and oxygenation.

Patient Profile

Demographics:

67-year-old male, retired school teacher

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Chronic Kidney Disease (Stage 3)

• Current medications: Lisinopril, Metformin, Insulin glargine, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Shortness of breath and confusion

• Key symptoms: Fever, chills, decreased urine output, increasing confusion, shortness of breath

• Vital signs: Temperature 39.3°C (102.7°F), Heart Rate 118 bpm, Blood Pressure 85/50 mmHg, Respiratory Rate 24 breaths per minute, Oxygen Saturation 90% on room air

Section 1

As the healthcare team conducts the initial assessment, they observe that the patient's condition is rapidly deteriorating. His shortness of breath has become more pronounced, and he is now requiring supplemental oxygen to maintain an oxygen saturation of above 90%. Upon auscultation, diminished breath sounds and crackles are noted in the lower lung fields, suggesting possible pulmonary involvement. The patient is increasingly disoriented, struggling to recall basic information, and is unable to follow simple commands, indicating worsening neurological status. Peripheral perfusion is poor, with cool, clammy extremities and delayed capillary refill time of over 4 seconds, highlighting the severity of the circulatory compromise.

Laboratory results reveal a marked leukocytosis with a white blood cell count of 18,000/mm³, an elevated lactate level at 4.5 mmol/L, and worsening renal function with a serum creatinine of 2.5 mg/dL, compared to 1.8 mg/dL on a previous baseline. Blood cultures are pending, but the clinical picture strongly suggests septic shock with potential acute kidney injury due to both the underlying chronic kidney disease and the current insult. Arterial blood gas analysis shows metabolic acidosis with a pH of 7.28 and bicarbonate level of 18 mEq/L, indicative of tissue hypoperfusion and subsequent lactic acidosis.

In response to the critical findings, the team initiates aggressive fluid resuscitation with crystalloid solutions and administers broad-spectrum antibiotics, avoiding penicillin due to the patient's allergy. Despite these efforts, the patient's blood pressure remains low, necessitating the start of vasopressor therapy to maintain adequate mean arterial pressure and improve organ perfusion. The healthcare team is acutely aware of the risk of progressing to multi-organ dysfunction syndrome (MODS) and is closely monitoring for any signs of further complications, such as acute respiratory distress syndrome (ARDS) or worsening renal failure, to adjust the treatment plan accordingly.

Section 2

The healthcare team observes a change in the patient's status approximately two hours after initiating vasopressor therapy. While there is a slight improvement in blood pressure, now hovering around 90/60 mmHg, new complications arise in the form of respiratory distress. The patient's respiratory rate has increased to 34 breaths per minute, and his oxygen saturation begins to drop again despite being on 60% oxygen via a non-rebreather mask. Repeat auscultation reveals worsening crackles throughout the lung fields, and the patient is exhibiting increased use of accessory muscles, indicating significant respiratory compromise. These findings raise concern for the development of acute respiratory distress syndrome (ARDS), a known complication of sepsis.

In light of the suspected ARDS and the patient's declining respiratory function, the healthcare team decides to prepare for intubation and mechanical ventilation to ensure adequate oxygenation and ventilation. A repeat chest X-ray is ordered, which reveals bilateral infiltrates consistent with pulmonary edema, further supporting the diagnosis of ARDS. The patient's arterial blood gas is re-evaluated and shows a worsening respiratory acidosis with a pH of 7.22, PaCO2 of 58 mmHg, and a PaO2 of 55 mmHg, despite supplemental oxygen.

As the patient is intubated and placed on a ventilator, the team carefully adjusts ventilator settings to optimize oxygenation while minimizing barotrauma risk. The need for continuous sedation is assessed to ensure patient comfort and synchronization with the ventilator. Throughout this process, the team remains vigilant for signs of other organ dysfunctions, such as worsening renal failure or new cardiac complications. The patient's fluid balance is meticulously monitored, considering both the risk of fluid overload in the setting of ARDS and the necessity of maintaining adequate perfusion to prevent further renal injury. The team is acutely aware that any further deterioration could lead to full-blown multi-organ dysfunction syndrome, necessitating rapid and precise adjustments to the treatment plan.

Section 3

As the healthcare team continues to manage the patient's condition, they note new diagnostic results that provide further insight into the evolving situation. A comprehensive metabolic panel reveals a concerning trend: the patient's serum creatinine level has risen to 2.8 mg/dL, up from a baseline of 1.0 mg/dL, indicating a significant decline in renal function. Additionally, the patient's lactate level remains elevated at 4.5 mmol/L, suggesting ongoing tissue hypoperfusion despite the partial stabilization of blood pressure with vasopressor therapy. These findings are suggestive of acute kidney injury secondary to sepsis, raising alarms about potential progression to multi-organ dysfunction syndrome.

In light of these findings, the team conducts a thorough review of the patient's fluid status and medication regimen. They decide to initiate continuous renal replacement therapy (CRRT) to manage the patient's fluid overload and support renal function. The decision is made to adjust the vasopressor dosage carefully to maintain adequate mean arterial pressure while avoiding further renal compromise. Additionally, the team reviews the patient's antimicrobial therapy to ensure appropriate coverage and considers consulting infectious disease specialists for potential adjustments based on culture results and sensitivity patterns.

Simultaneously, the patient's cardiac status is monitored closely for signs of septic cardiomyopathy, given the stress of sepsis and ARDS on the heart. Although the troponin level is slightly elevated at 0.12 ng/mL, there is no evidence of acute myocardial infarction on the electrocardiogram. The team decides to continue monitoring cardiac biomarkers and echocardiographic parameters. By addressing these new complications with targeted interventions and vigilant monitoring, the healthcare team aims to stabilize the patient and prevent further deterioration, acknowledging that the path to recovery in severe sepsis and ARDS is fraught with challenges and requires constant reassessment and adaptability.

Section 4

As the healthcare team continues to manage the patient's condition, a new complication emerges: the patient develops a significant increase in respiratory distress. Despite being on mechanical ventilation, the patient's oxygen saturation begins to drop steadily, now reading at 86% on a fraction of inspired oxygen (FiO2) of 0.7. Auscultation of the lungs reveals diffuse crackles and decreased breath sounds bilaterally, suggesting worsening pulmonary function. A repeat chest X-ray shows progression of infiltrates consistent with acute respiratory distress syndrome (ARDS), raising concerns about the adequacy of current ventilator settings and the potential need for advanced respiratory support techniques, such as prone positioning or extracorporeal membrane oxygenation (ECMO).

Simultaneously, the patient's laboratory results reveal a drop in hemoglobin to 8.5 g/dL, coupled with a decrease in platelet count to 90,000/µL, indicating possible disseminated intravascular coagulation (DIC), a known complication of severe sepsis. The prothrombin time (PT) and activated partial thromboplastin time (aPTT) are mildly prolonged, supporting this suspicion. The team recognizes the critical nature of these findings and initiates a multi-faceted approach to stabilize the patient. This includes optimizing ventilator support to improve oxygenation, administering blood products as necessary to address coagulopathy, and re-evaluating antimicrobial therapy to ensure it remains effective against the identified pathogens.

Despite these challenges, the team remains focused on delivering comprehensive care, emphasizing the importance of regular reassessment and timely intervention. The continuous monitoring of respiratory parameters, coagulation profiles, and hemodynamic stability is crucial in guiding clinical decisions. By maintaining a proactive approach, the healthcare team aims to prevent further progression to multi-organ dysfunction syndrome (MODS) and support the patient's journey towards recovery.

Section 5

As the healthcare team continues to closely monitor the patient, a new complication emerges, prompting further investigation. The patient's urine output decreases significantly over the next 12 hours, dropping to less than 0.3 mL/kg/hr, raising concerns about acute kidney injury (AKI), another potential complication of sepsis. Blood urea nitrogen (BUN) and creatinine levels are checked and found to be elevated at 28 mg/dL and 2.3 mg/dL, respectively, indicating a decline in renal function. The team considers the potential causes, including hypoperfusion due to hypotension, nephrotoxic effects of antimicrobial therapy, or underlying sepsis-related organ dysfunction.

This development necessitates a re-evaluation of the patient's fluid status and hemodynamic stability. The team reviews the patient's fluid balance and decides to cautiously administer intravenous fluids while carefully monitoring the central venous pressure (CVP) and urine output to prevent fluid overload, given the existing respiratory compromise. Additionally, the need for renal replacement therapy is discussed, especially if oliguria persists or worsens despite optimal fluid management. The nephrology team is consulted to provide further guidance on managing the emerging renal complications.

The patient’s complex condition underscores the importance of integrated care and the need for timely interventions across multiple systems. The healthcare team remains vigilant, conducting frequent assessments to monitor for signs of further deterioration or improvement. This dynamic situation requires the team to continually adapt their management strategies, balancing aggressive treatment of sepsis and its complications with supportive care tailored to the patient's evolving clinical needs. As the patient continues to battle against sepsis and its complications, the team remains committed to optimizing outcomes and supporting the patient’s recovery journey.